p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability

Linda Fabris1, Stefania Berton1, Ilenia Pellizzari1

  • 1Division of Experimental Oncology 2, Department of Translational Research, Centro di Riferimento Oncologico (CRO Aviano), National Cancer Institute, 33081 Aviano, Italy;

Insights

The cell cycle regulator p27(kip1) controls cell proliferation by stabilizing microtubules and influencing Ras-MAPK signaling. Deleting stathmin impairs p27(kip1)

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The cyclin-dependent kinase (CDK) inhibitor p27(kip1) is a key regulator of cell cycle progression and microtubule (MT) stability.
  • p27(kip1) modulates MT stability via stathmin interaction and direct MT binding.
  • Previous studies suggest a CDK-independent role for p27(kip1) in cell proliferation control.

Purpose of the Study:

  • To investigate the impact of p27(kip1)-mediated MT stability on cell cycle entry and signaling pathways.
  • To elucidate the molecular mechanisms by which p27(kip1) and stathmin regulate cell proliferation.
  • To identify the role of the p27(kip1)-stathmin axis in Ras-MAPK pathway activation.

Main Methods:

  • Gene expression profiling and bioinformatic analyses.
  • Studies using p27(kip1)-null and p27(kip1)/stathmin double-knockout (KO) mouse models.
  • Analysis of H-Ras trafficking and ubiquitination levels.

Main Results:

  • Concomitant deletion of stathmin impaired faster cell cycle entry in p27(kip1)-null cells.
  • p27(kip1) and stathmin were found to jointly control MAPK pathway activation.
  • p27(kip1) regulates H-Ras trafficking and ubiquitination, thereby restraining its activation through MT stability control.

Conclusions:

  • p27(kip1) controls G1/S-phase transition via MT stability and Ras-MAPK signaling.
  • The p27(kip1)-stathmin interaction fine-tunes the spatiotemporal activation of the Ras-MAPK pathway.
  • This study reveals a novel regulatory axis impacting cell cycle progression and signaling.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K